JNJ Johnson & Johnson
$254.78 +0.73%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
+0.73%
YTD
+34.90%
P/E
29.47
P/B
6.13
ROE
25.7%
Div yield
3.1%
Beta
-0.18
Market cap
$620.1B
RSI (14)
33
Next earnings
Oct 13, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$254.15
Close
$254.78
VWAP (n/a)
—
Day high
$255.48
Day low
$251.17
Volume
5.7M
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
Two of America’s Biggest Money Voices Give Opposite Advice on Dividend Stocks
Yahoo Finance · Oct 6
Johnson & Johnson CEO Says AI Has to Be Embraced
Yahoo Finance · Oct 6
Johnson & Johnson's Innovative Medicines Momentum Offsets MedTech Headwinds, RBC Capital Markets Says
Yahoo Finance · Oct 6
PFE vs. JNJ: Which Stock Is the Better Value Option?
Yahoo Finance · Oct 6
Can J&J's MedTech Business Rebound in Q3 After Q2 Slowdown?
Yahoo Finance · Oct 6
Johnson & Johnson (JNJ) Earnings Expected to Grow: Should You Buy?
Yahoo Finance · Oct 6
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
8-K Aug 4, 2026 View → 8-K Jul 29, 2026 View → 8-K Jul 28, 2026 View → 10-Q Jul 23, 2026 View → 8-K Jul 15, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell JNJ. Try it in the Lab to size a position and see the risk.